Global Remote Patient Monitoring And Care Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2024 –2030 |
 Tamanho do mercado (ano base ) | USD 25,769.22 million |
 Tamanho do mercado ( Ano de previsão) | |
 CAGR |
% |
| Principais participantes do mercado |
>Mercado global de monitorização e atendimento remoto de doentes, por tipo de dispositivo (dispositivos de monitorização cardíaca, dispositivos de monitorização da pressão arterial, dispositivos de monitorização da glicemia, dispositivos de monitorização respiratória, dispositivos de monitorização neurológica, dispositivos de monitorização multiparâmetros, entre outros), aplicação (oncologia, diabetes, Doenças Cardiovasculares e Outras), Utente Final (Doentes Hospitalares, Doentes Ambulatório e Doentes de Assistência Médica Domiciliária) - Tendências e Previsões do Sector para 2030.
Monitorização Remota de Doentes e Análise de Mercado de Cuidados e Insights
A abordagem RPM e de cuidados à prestação de cuidados de saúde tornou-se cada vez mais popular nos últimos anos, especialmente devido à pandemia de COVID-19, que levou a um aumento da procura de opções de cuidados remotos. A crescente consciencialização sobre a RPM e os cuidados em todo o mundo aumentou a procura do mercado. O aumento dos gastos em saúde para melhores serviços de saúde também contribui para o crescimento do mercado. Os principais players do mercado concentram-se em diversos lançamentos e aprovações de serviços durante este período crucial. Além disso, o aumento do avanço tecnológico dos dispositivos também contribui para o aumento da procura de RPM e cuidados.
Espera-se que o mercado global de monitorização e assistência remota de doentes cresça no ano previsto devido ao aumento dos participantes do mercado e à disponibilidade de dispositivos avançados de monitorização remota. Juntamente com isto, os fabricantes estão empenhados na atividade de desenvolvimento para lançar novos dispositivos e produtos RPM eficientes e precisos no mercado. O crescente desenvolvimento no campo das técnicas avançadas de saúde está a impulsionar ainda mais o crescimento do mercado. No entanto, espera-se que dificuldades como as regulamentações rigorosas para a produção e comercialização de RPM e produtos de cuidado restrinjam o crescimento do mercado no período de previsão.
Espera-se que o aumento dos gastos com a saúde no avanço e desenvolvimento proporcione oportunidades para o crescimento do mercado. No entanto, espera-se que o elevado custo dos dispositivos de monitorização e cuidados remotos represente um desafio ao crescimento do mercado.
Várias empresas estão a tomar iniciativas que levam gradualmente ao crescimento do mercado.
Por exemplo,
- Em janeiro de 2023, a CoachCare anunciou que adquiriu a empresa de RPM NVOLVE, sediada em Winston-Salem, para expandir a sua experiência em RPM nas áreas da dor, coluna vertebral e ortopedia. Esta aquisição ajudaria a empresa no seu portfólio de produtos e na expansão do negócio.
A Data Bridge Market Research analisa que o mercado global de monitorização e cuidados remotos de doentes deverá atingir um valor de 25.769,22 milhões de dólares até 2030, com um CAGR de 12,5% durante o período de previsão de 2023-2030.
|
Métrica de reporte |
Detalhes |
|
Período de previsão |
2023 a 2030 |
|
Ano base |
2022 |
|
Ano histórico |
2021 (personalizável para 2015 – 2020) |
|
Unidades Quantitativas |
Receita em milhões de dólares |
|
Segmentos cobertos |
Device Type (Cardiac Monitoring Devices, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Respiratory Monitoring Devices, Neurological Monitoring Devices, Multi-Parameter Monitoring Devices, and Others), Application (Oncology, Diabetes, Cardiovascular Diseases, and Others), End User (Hospital-Based Patients, Ambulatory Patients, and Home Healthcare Patients) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Belgium, Turkey, Netherlands, Russia, Switzerland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa |
|
Market Players Covered |
Medtronic, Boston Scientific Corporation, VitalConnect, Biobeat, General Electric, Koninklijke Philips N.V., OMRON Corporation, Abbott, Nihon Kohden Corporation, Vivify Health, Inc., Aerotel Medical Systems, BIOTRONIK SE & Co. KG, A&D Company, Limited, AliveCor, Inc., Masimo, Dexcom, Inc., Senseonics, Inc., ResMed, 100Plus., ChroniSense Medical, Ltd., Vitls, cardiomo, CoachCare, neteera, and Withings among others |
Market Definition
Remote Patient Monitoring (RPM) and care is a healthcare delivery model that allows healthcare providers to monitor patients remotely, using various technological devices and communication tools, without the need for face-to-face visits. This approach enables healthcare providers to deliver care and track patient health data from a distance, often in real time.
RPM typically involves the use of sensors-enabled wearable devices and other technological devices that can track a patient's vital signs, medication adherence, physical activity, and other health-related information. The collected data is then transmitted to healthcare providers who can analyze the information and take appropriate action, such as adjusting medication dosages, providing guidance on lifestyle changes, or scheduling follow-up appointments.
Global Remote Patient Monitoring and Care Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Driver
- Increasing Prevalence of Chronic Diseases
The market is expanding due to various causes, including the increasing prevalence of chronic diseases. Chronic diseases are non-communicable illnesses that last long and necessitate continuing medical care and management.
According to the World Health Organization, chronic diseases account for nearly 70% of all deaths worldwide, with cardiovascular disease being the primary cause. The rising prevalence of chronic diseases is increasing due to many variables, including an aging population, sedentary lifestyles, poor nutrition, and environmental factors. RPM and care can help healthcare providers to manage chronic diseases more efficiently and effectively.
As a result of the sedentary lifestyle of people, the prevalence of lifestyle-associated disorders such as hypertension and diabetes witnessed a rise. Thus, the rising prevalence of chronic diseases with the growing integration of healthcare data with portable devices is expected to demand proper health management, leading to the anticipated increasing demand for RPM and care in the market in the forecast period.
Restraint
- Strict Regulatory Framework
Regulatory bodies play a critical role in ensuring that remote patient monitoring technologies meet safety and quality standards and protect patient privacy. However, regulatory compliance can be a significant barrier to entry for many companies and may slow down the adoption of remote patient monitoring technologies.
The medical device regulations hold significant responsibility for safeguarding the health of the people in the medical device industry itself. The regulations require manufacturers to inculcate quality systems (based on internationally accepted standards for quality systems) into the design process for class III and IV devices. They also require manufacturers to incorporate them into the manufacturing process for class II, III, and IV devices.
Along with such strict regulations of medical devices, it has also been reported that Health Canada’s decision related to medical device applications is not timely. It involves reviewing the submission of scientific evidence by manufacturers to ensure the efficacy of various devices.
This suggests that such a tedious procedure led to the development of other technologically advanced devices and hence, poses a big challenge in front of device manufacturers in submitting the approval documentation.
The regulations imposed would delay the supply of the instrumentation and long-time approval for the devices. This factor is expected to act as a restraint for market growth.
Opportunity
-
Strategic Initiatives by Market Players
The strategic initiatives taken by the key market players have helped in the rise in technologies and advancements in remote patient monitoring products and devices. They are taking initiatives such as product launches, collaborations, mergers, and acquisitions among others, which is expected to create more opportunities for market growth.
Healthcare product suppliers have a huge opportunity to work with new technology firms to ensure the industry's continued growth, creativity, and viability.
To discover and develop advanced remote monitoring facilities, companies are launching new initiatives and collaborating with other key players to deliver more reliable results and services.
Estas iniciativas estratégicas como lançamentos de produtos, homologações, aquisições e fusões realizadas por grandes empresas do mercado abriram oportunidades para empresas de diversas regiões. Esta estratégia está a permitir às empresas reforçar a sua presença no mercado. Assim sendo, prevê-se que a iniciativa estratégica deverá proporcionar uma oportunidade para o crescimento do mercado.
Desafio
- Falta de profissionais qualificados
A monitorização remota de doentes requer uma variedade de profissionais com conhecimento e experiência especializados, incluindo médicos, técnicos e analistas de dados.
Os médicos são responsáveis por monitorizar remotamente a saúde do paciente e interpretar os dados recolhidos pelos dispositivos de monitorização remota do paciente.
Além disso, os técnicos são responsáveis pela instalação, manutenção e resolução de problemas dos dispositivos de monitorização remota de pacientes. Os analistas de dados são responsáveis por analisar os dados recolhidos pelos dispositivos de monitorização remota de doentes e fornecer insights aos profissionais de saúde. No entanto, existe actualmente uma escassez de analistas de dados, médicos e técnicos com as competências e experiência necessárias para fornecer informações significativas a partir de dados de monitorização remota de doentes.
A falta de profissionais qualificados pode também limitar a adoção das tecnologias RPM e limitar o seu potencial para melhorar os resultados dos cuidados de saúde. Sem profissionais qualificados, os prestadores de cuidados de saúde podem ter dificuldade em interpretar os dados dos doentes e em fornecer intervenções adequadas, limitando a eficácia do RPM na melhoria dos resultados dos doentes. Assim, a falta de profissionais qualificados é um fator significativo que deverá representar um desafio ao crescimento do mercado.
Desenvolvimentos recentes
- Em janeiro de 2023, a Masimo e a Philips anunciaram uma expansão da sua parceria para aumentar as capacidades de monitorização de pacientes em aplicações domésticas de telessaúde com o relógio avançado de rastreio de saúde Masimo W1. Esta extensão de colaboração ajudaria a empresa na expansão do portfólio de produtos de monitorização remota de doentes.
- Em dezembro de 2022, a Masimo anunciou o lançamento completo no mercado do Índice de Hidratação (Hi) para o relógio Masimo W1. O Masimo W1, um wearable avançado de monitorização de saúde, é o primeiro relógio a oferecer medições precisas e contínuas de oximetria de pulso e dados de saúde esclarecedores, do líder em oximetria de pulso hospitalar. Esta atualização do produto ajudaria a empresa na expansão do negócio do produto.
Âmbito global do mercado de monitorização e cuidados remotos de doentes
O mercado global de monitorização e atendimento remoto de pacientes está segmentado em três segmentos notáveis, como o tipo de dispositivo, a aplicação e o utilizador final. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
Tipo de dispositivo
- Dispositivos de monitorização cardíaca
- Dispositivos de monitorização da pressão arterial
- Dispositivos de monitorização da glicose no sangue
- Dispositivos de monitorização respiratória
- Dispositivos de monitorização neurológica
- Dispositivos de monitorização multiparâmetros
- Outros
Com base no tipo de dispositivo, o mercado está segmentado em dispositivos de monitorização cardíaca, dispositivos de monitorização da pressão arterial, dispositivos de monitorização da glicemia, dispositivos de monitorização respiratória, dispositivos de monitorização neurológica, dispositivos de monitorização multiparâmetros, entre outros.
Aplicação
- Oncologia
- Diabetes
- Doenças Cardiovasculares
- Outros
Com base na aplicação, o mercado está segmentado em oncologia, diabetes, doenças cardiovasculares, entre outras.
Utilizador final
- Pacientes Hospitalares
- Pacientes Ambulatoriais
- Doentes de saúde domiciliar
Com base no utilizador final, o mercado está segmentado em doentes hospitalares, doentes externos e doentes de saúde domiciliária.
Análise/perspetivas regionais do mercado global de monitorização e cuidados remotos de doentes
O mercado global de monitorização e atendimento remoto de pacientes está segmentado em três segmentos notáveis, como o tipo de dispositivo, a aplicação e o utilizador final.
Os países abrangidos neste relatório de mercado são os EUA, Canadá, México, Alemanha, França, Reino Unido, Itália, Espanha, Bélgica, Turquia, Países Baixos, Rússia, Suíça, Resto da Europa, China, Japão, Índia, Coreia do Sul, Austrália , Singapura , Tailândia, Malásia, Indonésia, Filipinas, Resto da Ásia-Pacífico, Brasil, Argentina, Resto da América do Sul, África do Sul, Arábia Saudita, Emirados Árabes Unidos, Egito, Israel e Resto do Médio Oriente e África.
Espera-se que a América do Norte domine o mercado global de monitorização e cuidados remotos de doentes devido ao crescente investimento em RPM e cuidados, o que deverá impulsionar o crescimento do mercado. Espera-se que os EUA dominem a região da América do Norte devido ao aumento do avanço tecnológico nas RPM e nos produtos de cuidado. Prevê-se que a Alemanha domine a região da Europa devido à crescente procura por parte dos mercados emergentes e à expansão. Espera-se que a China domine a região Ásia-Pacífico devido à crescente inclinação dos clientes para processos tecnológicos avançados.
A secção de países do relatório também fornece fatores individuais que impactam o mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais, e o impacto dos canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país .
Cenário competitivo e análise global da quota de mercado de monitorização e cuidados remotos de doentes
O panorama competitivo do mercado global de monitorização e atendimento remoto de pacientes fornece detalhes dos concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em I&D, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, aprovações de produtos, largura e amplitude do produto, domínio de aplicação e tipo de produto curva da linha de vida. Os dados fornecidos acima estão apenas relacionados com o foco da empresa no mercado.
Alguns dos principais players do mercado que operam no mercado global de monitorização e assistência remota de doentes são a Medtronic, Boston Scientific Corporation, VitalConnect, Biobeat, General Electric, Koninklijke Philips NV, OMRON Corporation, Abbott, Nihon Kohden Corporation, Vivify Health, Inc. , Aerotel KG, A&D Company, Limited, AliveCor, Inc., Masimo, Dexcom, Inc., Senseonics, Inc., ResMed, 100Plus., ChroniSense Medical, Ltd., Vitls, cardiomo, CoachCare, neteera e Withings, entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 VALUE CHAIN ANALYSIS:
4.3 COMPETITIVE ANALYSIS
4.4 BRAND ANALYSIS
4.5 ECOSYSTEM MAPS
4.6 TECHNOLOGICAL TRENDS
4.7 TOP WINNING STRATEGIES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING
5.1.4 INCREASING GOVERNMENT INITIATIVES
5.2 RESTRAINTS
5.2.1 STRICT REGULATORY FRAMEWORK
5.2.2 LACK OF STANDARDIZATION
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS
5.4.2 RISK TO PATIENT'S DATA SECURITY
6 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE
6.1 OVERVIEW
6.2 CARDIAC MONITORING DEVICES
6.3 BLOOD PRESSURE MONITORING DEVICES
6.4 MULTI-PARAMETER MONITORING DEVICES
6.5 BLOOD GLUCOSE MONITORING DEVICES
6.6 RESPIRATORY MONITORING DEVICES
6.7 NEUROLOGICAL MONITORING DEVICES
6.8 OTHERS
7 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CARDIOVASCULAR DISEASE
7.2.1 CORONARY HEART DISEASE
7.2.2 STROKE
7.2.3 PERIPHERAL ARTERIAL DISEASE
7.2.4 AORTIC DISEASE
7.2.5 OTHERS
7.3 DIABETES
7.4 ONCOLOGY
7.5 OTHERS
8 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER
8.1 OVERVIEW
8.2 HOME HEALTHCARE PATIENTS
8.2.1 BLOOD GLUCOSE MONITORING DEVICES
8.2.2 CARDIAC MONITORING DEVICES
8.2.3 BLOOD PRESSURE MONITORING DEVICES
8.2.4 MULTI-PARAMETER MONITORING DEVICES
8.2.5 RESPIRATORY MONITORING DEVICES
8.2.6 NEUROLOGICAL MONITORING DEVICES
8.2.7 OTHERS
8.3 AMBULATORY PATIENTS
8.3.1 MULTI-PARAMETER MONITORING DEVICES
8.3.2 RESPIRATORY MONITORING DEVICES
8.3.3 CARDIAC MONITORING DEVICES
8.3.4 BLOOD PRESSURE MONITORING DEVICES
8.3.5 BLOOD GLUCOSE MONITORING DEVICES
8.3.6 NEUROLOGICAL MONITORING DEVICES
8.3.7 OTHERS
8.4 HOSPITAL-BASED PATIENTS
8.4.1 MULTI-PARAMETER MONITORING DEVICES
8.4.2 CARDIAC MONITORING DEVICES
8.4.3 RESPIRATORY MONITORING DEVICES
8.4.4 BLOOD PRESSURE MONITORING DEVICES
8.4.5 BLOOD GLUCOSE MONITORING DEVICES
8.4.6 NEUROLOGICAL MONITORING DEVICES
8.4.7 OTHERS
9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 RUSSIA
9.3.6 SPAIN
9.3.7 TURKEY
9.3.8 SWITZERLAND
9.3.9 NETHERLANDS
9.3.10 BELGIUM
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 AUSTRALIA
9.4.4 INDIA
9.4.5 SOUTH KOREA
9.4.6 SINGAPORE
9.4.7 MALAYSIA
9.4.8 THAILAND
9.4.9 INDONESIA
9.4.10 PHILIPPINES
9.4.11 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 ARGENTINA
9.5.3 REST OF SOUTH AMERICA
9.6 MIDDLE EAST AND AFRICA
9.6.1 SOUTH AFRICA
9.6.2 EGYPT
9.6.3 ISRAEL
9.6.4 UAE
9.6.5 SAUDI ARABIA
9.6.6 REST OF MIDDLE EAST AND AFRICA
10 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 DEXCOM, INC.
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 RESMED
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BIOTRONIK SE & CO. KG
12.5.1 COMPANY SNAPSHOT
12.5.2 COMPANY SHARE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENT
12.6 100 PLUS.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 A&D COMPANY, LIMITED
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 COMPANY SHARE ANALYSIS
12.7.4 PRODUCT PORTFOLIO
12.7.5 RECENT DEVELOPMENT
12.8 AEROTEL MEDICAL SYSTEMS
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 ALIVECOR, INC.
12.9.1 COMPANY SNAPSHOT
12.9.2 COMPANY SHARE ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS
12.1 BIOBEAT
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 BOSTON SCIENTIFIC CORPORATION
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 COMPANY SHARE ANALYSIS
12.11.4 PRODUCT PORTFOLIO
12.11.5 RECENT DEVELOPMENT
12.12 CARDIOMO
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 CHRONISENSE MEDICAL, LTD.
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENT
12.14 COACHCARE
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENT
12.15 GENERAL ELECTRIC
12.15.1 COMPANY SNAPSHOT
12.15.2 REVENUE ANALYSIS
12.15.3 COMPANY SHARE ANALYSIS
12.15.4 PRODUCT PORTFOLIO
12.15.5 RECENT DEVELOPMENT
12.16 KONINKLIJKE PHILIPS N.V.
12.16.1 COMPANY SNAPSHOT
12.16.2 REVENUE ANALYSIS
12.16.3 COMPANY SHARE ANALYSIS
12.16.4 PRODUCT PORTFOLIO
12.16.5 RECENT DEVELOPMENT
12.17 MASIMO
12.17.1 COMPANY SNAPSHOT
12.17.2 REVENUE ANALYSIS
12.17.3 COMPANY SHARE ANALYSIS
12.17.4 PRODUCT PORTFOLIO
12.17.5 RECENT DEVELOPMENT
12.18 NETEERA
12.18.1 COMPANY SNAPSHOT
12.18.2 PRODUCT PORTFOLIO
12.18.3 RECENT DEVELOPMENT
12.19 NIHON KOHDEN CORPORATION
12.19.1 COMPANY SNAPSHOT
12.19.2 REVENUE ANALYSIS
12.19.3 COMPANY SHARE ANALYSIS
12.19.4 PRODUCT PORTFOLIO
12.19.5 RECENT DEVELOPMENT
12.2 OMRON CORPORATION
12.20.1 COMPANY SNAPSHOT
12.20.2 REVENUE ANALYSIS
12.20.3 COMPANY SHARE ANALYSIS
12.20.4 PRODUCT PORTFOLIO
12.20.5 RECENT DEVELOPMENT
12.21 SENSEONICS, INC.
12.21.1 COMPANY SNAPSHOT
12.21.2 REVENUE ANALYSIS
12.21.3 COMPANY SHARE ANALYSIS
12.21.4 PRODUCT PORTFOLIO
12.21.5 RECENT DEVELOPMENT
12.22 VITALCONNECT
12.22.1 COMPANY SNAPSHOT
12.22.2 PRODUCT PORTFOLIO
12.22.3 RECENT DEVELOPMENT
12.23 VITLS
12.23.1 COMPANY SNAPSHOT
12.23.2 PRODUCT PORTFOLIO
12.23.3 RECENT DEVELOPMENT
12.24 VIVIFY HEALTH INC.
12.24.1 COMPANY SNAPSHOT
12.24.2 PRODUCT PORTFOLIO
12.24.3 RECENT DEVELOPMENTS
12.25 WITHINGS
12.25.1 COMPANY SNAPSHOT
12.25.2 COMPANY SHARE ANALYSIS
12.25.3 PRODUCT PORTFOLIO
12.25.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
Lista de Tabela
TABLE 1 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 2 GLOBAL CARDIAC MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL BLOOD PRESSURE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL MULTI-PARAMETER MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL BLOOD GLUCOSE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL RESPIRATORY MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL NEUROLOGICAL MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 GLOBAL CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL DIABETES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 GLOBAL ONCOLOGY IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 GLOBAL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 31 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 32 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 33 U.S. CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 34 U.S. REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 35 U.S. HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 36 U.S. AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 37 U.S. HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 38 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 39 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 CANADA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 41 CANADA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 CANADA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 43 CANADA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 44 CANADA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 45 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 46 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 47 MEXICO CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 48 MEXICO REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 49 MEXICO HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 50 MEXICO AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 51 MEXICO HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 52 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 53 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 54 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 EUROPE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 56 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 57 EUROPE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 58 EUROPE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 59 EUROPE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 60 GERMANY REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 61 GERMANY REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 62 GERMANY CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 63 GERMANY REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 64 GERMANY HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 65 GERMANY AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 66 GERMANY HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 67 U.K REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 68 U.K REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 U.K CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 U.K REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 71 U.K HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 72 U.K AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 73 U.K HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 74 FRANCE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 75 FRANCE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 FRANCE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 77 FRANCE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 78 FRANCE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 79 FRANCE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 80 FRANCE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 81 ITALY REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 82 ITALY REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 83 ITALY CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 84 ITALY REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 85 ITALY HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 86 ITALY AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 87 ITALY HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 88 RUSSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 89 RUSSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 RUSSIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 91 RUSSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 92 RUSSIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 93 RUSSIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 94 RUSSIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 95 SPAIN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 96 SPAIN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 97 SPAIN CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 98 SPAIN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 99 SPAIN HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 100 SPAIN AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 101 SPAIN HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 102 TURKEY REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 103 TURKEY REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 TURKEY CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 TURKEY REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 106 TURKEY HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 107 TURKEY AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 108 TURKEY HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 109 SWITZERLAND REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 110 SWITZERLAND REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 111 SWITZERLAND CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 112 SWITZERLAND REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 113 SWITZERLAND HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 114 SWITZERLAND AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 115 SWITZERLAND HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 116 NETHERLANDS REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 117 NETHERLANDS REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 118 NETHERLANDS CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 119 NETHERLANDS REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 NETHERLANDS HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 121 NETHERLANDS AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 122 NETHERLANDS HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 123 BELGIUM REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 124 BELGIUM REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 125 BELGIUM CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 126 BELGIUM REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 127 BELGIUM HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 128 BELGIUM AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 129 BELGIUM HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 130 REST OF EUROPE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 131 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 132 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 133 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 134 ASIA-PACIFIC CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 135 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 136 ASIA-PACIFIC HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 137 ASIA-PACIFIC AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 138 ASIA-PACIFIC HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 139 CHINA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 140 CHINA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 CHINA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 CHINA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 143 CHINA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 144 CHINA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 145 CHINA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 146 JAPAN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 147 JAPAN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 148 JAPAN CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 149 JAPAN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 150 JAPAN HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 151 JAPAN AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 152 JAPAN HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 153 AUSTRALIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 154 AUSTRALIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 155 AUSTRALIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 AUSTRALIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 AUSTRALIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 158 AUSTRALIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 159 AUSTRALIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 160 INDIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 161 INDIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 162 INDIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 163 INDIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 164 INDIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 165 INDIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 166 INDIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 167 SOUTH KOREA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 168 SOUTH KOREA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 SOUTH KOREA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 SOUTH KOREA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 171 SOUTH KOREA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 172 SOUTH KOREA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 173 SOUTH KOREA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 174 SINGAPORE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 175 SINGAPORE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 SINGAPORE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 SINGAPORE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 178 SINGAPORE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 179 SINGAPORE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 180 SINGAPORE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 181 MALAYSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 182 MALAYSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 183 MALAYSIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 184 MALAYSIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 185 MALAYSIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 186 MALAYSIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 187 MALAYSIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 188 THAILAND REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 189 THAILAND REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 190 THAILAND CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 191 THAILAND REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 192 THAILAND HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 193 THAILAND AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 194 THAILAND HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 195 INDONESIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 196 INDONESIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 197 INDONESIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 198 INDONESIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 199 INDONESIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 200 INDONESIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 201 INDONESIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 202 PHILIPPINES REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 203 PHILIPPINES REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 204 PHILIPPINES CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 205 PHILIPPINES REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 206 PHILIPPINES HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 207 PHILIPPINES AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 208 PHILIPPINES HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 209 REST OF ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 210 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 211 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 212 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 213 SOUTH AMERICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 214 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 215 SOUTH AMERICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 216 SOUTH AMERICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 217 SOUTH AMERICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 218 BRAZIL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 219 BRAZIL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 220 BRAZIL CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 221 BRAZIL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 222 BRAZIL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 223 BRAZIL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 224 BRAZIL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 225 ARGENTINA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 226 ARGENTINA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 227 ARGENTINA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 ARGENTINA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 229 ARGENTINA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 230 ARGENTINA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 231 ARGENTINA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 232 REST OF SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 233 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 234 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 235 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 236 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 238 MIDDLE EAST AND AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 239 MIDDLE EAST AND AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 240 MIDDLE EAST AND AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 241 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 242 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 243 SOUTH AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 245 SOUTH AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 246 SOUTH AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 247 SOUTH AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 248 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 249 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 EGYPT CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 251 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 252 EGYPT HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 253 EGYPT AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 254 EGYPT HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 255 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 256 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 257 ISRAEL CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 258 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 ISRAEL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 260 ISRAEL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 261 ISRAEL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 262 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 263 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 264 UAE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 265 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 266 UAE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 267 UAE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 268 UAE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 269 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 270 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 271 SAUDI ARABIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 272 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 273 SAUDI ARABIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 274 SAUDI ARABIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 275 SAUDI ARABIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 276 REST OF MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
Lista de Figura
FIGURE 1 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 2 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET IN THE FORECAST PERIOD
FIGURE 12 THE CARDIAC MONITORING DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET IN 2023 AND 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET AND EUROPE IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 EUROPE IS THE FASTEST-GROWING MARKET FOR THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET MANUFACTURERS IN THE FORECAST PERIOD
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET
FIGURE 16 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2022
FIGURE 17 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2023-2030 (USD MILLION)
FIGURE 18 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, CAGR (2023-2030)
FIGURE 19 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, LIFELINE CURVE
FIGURE 20 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2022
FIGURE 21 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 22 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 23 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 24 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2022
FIGURE 25 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 26 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 27 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, LIFELINE CURVE
FIGURE 28 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 29 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY REGION (2022)
FIGURE 30 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY REGION (2023 & 2030)
FIGURE 31 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY REGION (2022 & 2030)
FIGURE 32 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE (2023-2030)
FIGURE 33 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 34 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 35 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 36 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 37 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 38 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 40 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 43 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: SNAPSHOT (2022)
FIGURE 44 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: BY COUNTRY (2022)
FIGURE 45 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 46 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 47 ASIA-PACIFIC REMOTE PATIENT MONITORING MARKET: DEVICE TYPE (2023-2030)
FIGURE 48 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 49 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 50 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 51 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 52 SOUTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 53 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 54 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 55 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 56 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 57 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 58 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
FIGURE 59 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
FIGURE 60 EUROPE REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
FIGURE 61 ASIA-PACIFIC REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
